经皮胫骨近端穿刺减压治疗膝关节骨性关节炎  

The proximal tibial percutaneous puncture in the treatment of knee osteoarthritis

作　　者：谭纪锋[1] 张玮虹[1] 高明宏[1] 张世权[1] 刘安庆[1] 

机构地区：[1]深圳市第二人民医院骨关节外科,广东深圳100730

出　　处：《中国当代医药》2012年第17期31-32,共2页China Modern Medicine

摘　　要：目的研究经皮胫骨近端穿刺减压对膝关节骨性关节炎的治疗效果。方法选择2006年1月～2010年1月本院收治的骨关节炎患者183例,采用随机数表法分成治疗组和对照组,治疗组90例采用经皮胫骨近端穿刺减压治疗,同时口服布洛芬,2次/d,300 mg/次;对照组93例仅口服布洛芬,2次/d,300 mg/次。定期随访并评价疗效。结果 183例患者均定期随访,随访8～15个月,平均9.3个月,均未发现不良反应。治疗组前后休息痛、运动痛、压痛、肿胀、活动度、行走等6个方面积分均有改善(P<0.05),治疗组显效、改善的比例显著高于对照组(P<0.05)。结论经皮胫骨近端穿刺减压治疗能改善膝关节骨关节炎患者的症状体征,方法简单安全,无明显不良反应。Objective To investigate the therapeutic effect of proximal tibial percutaneous puncture （PTPP） in the treatment of knee osteoarthritis. Methods One hundred and eighty-three patients with knee osteoarthritis were divided into experi- mental group and control one. All patients took brufen 300 mg, bid, while the patients in experimental group were given PTPP treatment. All patients were followed up periodically. Results All patients were followed up periodically for 8-15 months, an average of 9.3 months. The clinical manifestation such as pains, swelling and so on in experimental group shows improvement （P 〈 0.05）. And the effective rate in experimental group was obviously higher than control group （P 〈 0.05）. Conclusion PTPP can improve the clinical manifestation of knee osteoarthritis patients. It is simple and safe, without obvious adverse reactions.

关 键 词：经皮胫骨近端穿刺减压术 膝关节骨关节炎 布洛芬 疗效 

分 类 号：R684.3[医药卫生—骨科学]